Filter News
Area of Research
News Topics
- (-) Advanced Reactors (1)
- (-) Biomedical (1)
- (-) Composites (2)
- (-) Energy Storage (1)
- (-) Quantum Science (2)
- 3-D Printing/Advanced Manufacturing (3)
- Bioenergy (2)
- Biology (1)
- Chemical Sciences (1)
- Climate Change (1)
- Computer Science (3)
- Critical Materials (1)
- Cybersecurity (1)
- Frontier (1)
- Fusion (1)
- Isotopes (2)
- ITER (1)
- Materials (4)
- Materials Science (2)
- Microscopy (5)
- Nanotechnology (7)
- Neutron Science (4)
- Nuclear Energy (2)
- Physics (3)
- Polymers (1)
- Quantum Computing (1)
Media Contacts
A world-leading researcher in solid electrolytes and sophisticated electron microscopy methods received Oak Ridge National Laboratory’s top science honor today for her work in developing new materials for batteries. The announcement was made during a livestreamed Director’s Awards event hosted by ORNL Director Thomas Zacharia.
Ten scientists from the Department of Energy’s Oak Ridge National Laboratory are among the world’s most highly cited researchers, according to a bibliometric analysis conducted by the scientific publication analytics firm Clarivate.
A team led by the ORNL has found a rare quantum material in which electrons move in coordinated ways, essentially “dancing.”
Sergei Kalinin, a scientist and inventor at the Department of Energy’s Oak Ridge National Laboratory, has been elected a fellow of the Microscopy Society of America professional society.
The Department of Energy’s Oak Ridge National Laboratory is collaborating with industry on six new projects focused on advancing commercial nuclear energy technologies that offer potential improvements to current nuclear reactors and move new reactor designs closer to deployment.
Scientists at the Department of Energy’s Oak Ridge National Laboratory have created a recipe for a renewable 3D printing feedstock that could spur a profitable new use for an intractable biorefinery byproduct: lignin.
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.